Association between SLC6A4 serotonin transporter gene linked polymorphic region and ADRA2A-1291C>G and irritable bowel syndrome in Korea

Journal of Neurogastroenterology and Motility

Volumn 20, Issue 3, 2014, Pages 388-399

  Choi, Yoon Jin ^a   Hwang, Sung Wook ^b   Kim, Nayoung ^a,b   Park, Ji Hyun ^b   Oh, Jane C ^c   Lee, Dong Ho ^a,b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Yonsei Plus Eye Center   (South Korea)

Author keywords

Irritable bowel syndrome; Polymorphism, genetic; Polymorphism, single nucleotide; Receptors, adrenergic; Serotonin

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; CHOLECYSTOKININ A RECEPTOR; GNB3 PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ADULT; ALLELE; ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IRRITABLE COLON; KOREA; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SEROTONIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84903980359     PISSN: 20930879     EISSN: 20930887     Source Type: Journal    
DOI: 10.5056/jnm14020     Document Type: Article

References (50)

1. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.
2. Saito YA, Schoenfeld P, Locke III GR 3rd. The epidemiology of irritable bowel syndrome in North America: a systematic review. Am J Gastroenterol 2002;97:1910-1915.
3. Locke GR 3rd. The epidemiology of functional gastrointestinal disorders in North America. Gastroenterol Clin North Am 1996;25:1-19.
4. Tack J, Masaoka T, Janssen P. Functional dyspepsia. Curr Opin Gastroenterol 2011;27:549-557.
5. Kaji M, Fujiwara Y, Shiba M, et al. Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 2010;25:1151-1156.
6. Ford AC, Talley NJ. Irritable bowel syndrome. BMJ 2012;345: e5836.
7. Saito YA. The role of genetics in IBS. Gastroenterolo Clin North Am 2011;40:45-67.
8. Van Tilburg MA, Whitehead WE. New paradigm for studying genetic contributions to irritable bowel syndrome. Dig Dis Sci 2012; 57:2484-2486.
9. Saito YA, Larson JJ, Atkinson EJ, et al. The Role of 5-HTT LPR and GNβ3 825C> T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). Dig Dis Sci 2012;57: 2650-2657.
10. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996;66:2621-2624.
11. Kim HJ, Camilleri M, Carlson PJ, et al. Association of distinct α2 adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders. Gut 2004;53:829-837.
12. Saito YA, Locke G 3rd, Zimmerman JM, et al. A genetic association study of 5-HTT LPR and GNβ3 C825T polymorphisms with irritable bowel syndrome. Neurogastroenterol Motil 2007;19:465-470.
13. Park SY, Rew JS, Lee SM, et al. Association of CCK1 receptor gene polymorphisms and irritable bowel syndrome in Korean. J Neurogastroenterol Motil 2010;16:71-76.
14. Sikander A, Rana SV, Sharma SK, et al. Association of alpha 2A adrenergic receptor gene (ADRA2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis. Clinica Chimica Acta 2010;411:59-63.
15. Tahara T, Shibata T, Nakamura M, et al. Homozygous TRPV1 315C influences the susceptibility to functional dyspepsia. J Clin Gastroenterol 2010;44:e1-e7.
16. Lario S, Calls J, Cases A, Oriola J, Torras A, Rivera F. MspI identifies a biallelic polymorphism in the promoter region of the α2A-adrenergic receptor gene. Clin Genet 1997;51:129-130.
17. Camilleri M, Katzka DA. Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol 2012;302:G1075-G1084.
18. Oshima T, Toyoshima F, Nakajima S, Fukui H, Watari J, Miwa H. Genetic factors for functional dyspepsia. J Gastroenterol Hepatol 2011;26(suppl 3):83-87.
19. Van Lelyveld N, Linde JT, Schipper M, Samsom M. Candidate genotypes associated with functional dyspepsia. Neurogastroenterol Motil 2008;20:767-773.
20. Holtmann G, Siffert W, Haag S, et al. G-protein β3 subunit 825 CC genotype is associated with unexplained (functional) dyspepsia. Gastroenterology 2004;126:971-979.
21. Harvey RF, Read AE. Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome. The Lancet 1973;301:1-3.
22. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008;57:923-929.
23. Noh YW, Jung HK, Kim SE, Jung SA. Overlap of erosive and non-erosive reflux diseases with functional gastrointestinal disorders according to Rome III criteria. J Neurogastroenterol Motil 2010;16: 148-156.
24. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-1491.
25. Wiśniewska-Jarosińska M, Harasiuk A, Walecka-Kapica E, Pawłowicz M, Stec-Michalska K, Chojnacki J. Postprandial secretion of serotonin and melatonin in patients with functional dyspepsia. Clin Exp Med Lett 2009;50:165-168.
26. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol 2000;95:2698-2709.
27. Lesch KP, Bengel D, Heils A, et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
28. Areeshi MY, Haque S, Panda AK, Mandal RK. A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis. PLoS One 2013;8:e75567.
29. Li Y, Nie Y, Xie J, et al. The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients. Dig Dis Sci 2007;52: 2942-2949.
30. Zhang ZF, Duan ZJ, Wang LX, Yang D, Zhao G, Zhang L. The serotonin transporter gene polymorphism (5-HTTLPR) and irritable bowel syndrome: a meta-analysis of 25 studies. BMC Gastroenterol 2014;14:23.
31. Su AM, Shih W, Presson AP, Chang L. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol Motil 2014;26:36-45.
32. Drossman DA, Morris CB, Hu Y, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005;128:580-589.
33. Weinland SR, Morris CB, Hu Y, Leserman J, Bangdiwala SI, Drossman DA. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment. Am J Gastroenterol 2011;106:1813-1820.
34. Yeo A, Boyd P, Lumsden S, et al. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 2004;53:1452-1458.
35. Park JM, Choi MG, Park JA, et al. Serotonin transporter gene polymorphism and irritable bowel syndrome. Neurogastroenterol Motil 2006;18:995-1000.
36. Kumar S, Ranjan P, Mittal B, Ghoshal UC. Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls. J Gastrointestin Liver Dis 2012;21:31-38.
37. Houghton LA, Atkinson W, Whitaker RP, Whorwell PJ, Rimmer MJ. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 2003;52:663-670.
38. Sikander A, Rana SV, Sinha SK, et al. Serotonin transporter promoter variant: analysis in Indian IBS patients and control population. J Clin Gastroenterol 2009;43:957-961.
39. Scheibner J, Trendelenburg AU, Hein L, Starke K, Blandizzi C. α2-Adrenoceptors in the enteric nervous system: a study in α2A-adrenoceptor-deficient mice. Br J Pharmacol 2002;135:697-704.
40. Liu L, Coupar IM. Role of α2-adrenoceptors in the regulation of intestinal water transport. Br J Pharmacol 1997;120:892-898.
41. Andresen V, Camilleri M, Kim HJ, et al. Is there an association between GNβ3-C825T genotype and lower functional gastrointestinal disorders? Gastroenterology 2006;130:1985-1994.
42. Kim HG, Lee KJ, Lim SG, Jung JY, Cho SW. G-protein beta3 subunit C825T polymorphism in patients with overlap syndrome of functional dyspepsia and irritable bowel syndrome. J Neurogastroenterol Motil 2012;18:205-210.
43. Markoutsaki T, Karantanos T, Gazouli M, Anagnou NP, Ladas SD, Karamanolis DG. Serotonin transporter and G protein beta3 subunit gene polymorphisms in Greeks with irritable bowel syndrome. Dig Dis Sci 2011;56:3276-3280.
44. Xu H, Tian W, Fu Y, Oyama TT, Anderson S, Cohen DM. Functional effects of nonsynonymous polymorphisms in the human TRPV1 gene. Am J Physiol Renal Physiol 2007;293:F1865-F1876.
45. Li X, Cao Y, Wong RK, Ho KY, Wilder-Smith CH. Visceral and somatic sensory function in functional dyspepsia. Neurogastroenterol Motil 2013;25:246,e165.
46. Song YA, Park SY, Park YL, et al. Association between single nucleotide polymorphisms of the transient receptor potential vanilloid 1 (TRPV-1) gene and patients with irritable bowel syndrome in Korean populations. Acta Gastroenterol Belg 2012;75:222-227.
47. Toya Y, Chiba T, Sugai T, Habano W, Suzuki K. Association between brain-gut peptide polymorphisms and irritable bowel syndrome. J Gastroenterol Hepatol Res 2013;2:576-580.
48. van Kerkhoven LA, Laheij RJ, Jansen JB. Meta-analysis: a functional polymorphism in the gene encoding for activity of the serotonin transporter protein is not associated with the irritable bowel syndrome. Aliment Pharmacol Ther 2007;26:979-986.
49. Ersryd A, Posserud I, Abrahamsson H, Simrén M. Subtyping the irritable bowel syndrome by predominant bowel habit: Rome II versus Rome III. Aliment Pharmacol Ther 2007;26:953-961.
50. Chang FY, Lu CL, Chen TS. The current prevalence of irritable bowel syndrome in Asia. J Neurogastroenterol Motil 2010;16:389-400.